Stock News and Filings Feed


Add BE
to your dashboard

Beleave Plans to Develop Novel Instrumentation and Methodologies for the Rapid In Situ Quantification of Micronutrient and Heavy Metal Content Found in Cannabis Plant Material

2017-08-01 marketwired
TORONTO, ON--(Marketwired - August 01, 2017) - Beleave Inc. ("Beleave" or the "Company") (CSE: BE) (CSE: BE.CN) (CNSX: BE) is pleased to announce that it is now beginning work on a technological development research project at Ryerson University, with the goal of developing and validating technologies that are able to quantify micronutrient and heavy metal content in the cannabis plant, in real time.

Don't Drive Hi campaign is buzzing -- Got a bad case of the munchies? Stay off the roads

2017-07-14 marketwired
TORONTO, ON--(Marketwired - July 14, 2017) - R.I.D.E CHECKS -- Don't add driving to your summer high! The warm weather often brings lots of cottage trips, festivals and concerts -- and sometimes the munchies too! Well, munch away but just don't get behind the wheel.

Beleave Sponsors Don't Drive Hi Campaign Aimed to Reduce Cannabis Impaired Driving

2017-07-14 marketwired
TORONTO, ON--(Marketwired - July 14, 2017) - Beleave Inc. ("Beleave" or the "Company") (CSE: BE) (CSE: BE.CN) (CNSX: BE) is pleased to be a sponsor and supporter of the Don't Drive Hi campaign, a campaign aimed to reduce cannabis impaired driving. With legislation for legalizing marijuana progressing, the year-long Don't Drive Hi campaign is backed by prominent sponsors including advertising agency BBDO, radio stations Z103.

Beleave Begins Cultivation at Hamilton Facility

2017-06-28 marketwired
TORONTO, ON--(Marketwired - June 28, 2017) - Beleave Inc. (CSE: BE) (CSE: BE.CN) (CNSX: BE) ("Beleave" or the "Company") is pleased to announce that since receiving its cultivation license, the growing space at its facility near Hamilton, Ontario has been prepared, and rooted starting material has been planted. The Company anticipates it will commence its first flowering cycle in the next week with this cycle, in its entirety, scheduled to last approximately eight weeks.

CFN Media Takes an Inside Look at Cannabis Wheaton with CEO Chuck Rifici

2017-06-09 marketwired
SEATTLE, WA--(Marketwired - Jun 9, 2017) - CFN Media Group ("CFN Media"), the leading agency and digital media network dedicated to legal cannabis, today announced publication of an article and exclusive CEO video interview discussing how Cannabis Wheaton Income Corp. (TSX VENTURE: CBW) is transforming the cannabis industry's investment model and changing the way companies work together.

Beleave Inc.: No Material Change

2017-06-06 marketwired
TORONTO, ON--(Marketwired - June 05, 2017) - Beleave Inc. (CSE: BE) (CSE: BE.CN) (CNSX: BE) ("Beleave" or the "Company"), at the request of the Investment Industry Regulatory Organization of Canada ("IRROC"), wishes to confirm that the Company's management is unaware of any material change in the Company's operations that would account for the recent share price depreciation.

Beleave Provides Corporate Update and Outlook After Receiving License to Cultivate Cannabis

2017-05-26 marketwired
TORONTO, ON --(Marketwired - May 26, 2017) - Beleave Inc. (CSE: BE) (CSE: BE.CN) (CNSX: BE) ("Beleave" or the "Company") recently received its Health Canada license to cultivate cannabis, and is pleased to provide shareholders with a corporate update that includes an overview of the Company's outlook for the remainder of the year.

Cannabis Wheaton Congratulates Its Partner Beleave Inc.

2017-05-19 marketwired
VANCOUVER, BC--(Marketwired - May 19, 2017) - Cannabis Wheaton Income Corp. (TSX VENTURE: CBW) ("Cannabis Wheaton", "CW", or the "Company") is pleased to report that First Access Medical Inc., the wholly-owned subsidiary of CW's partner Beleave Inc. ("Beleave") (CSE - BE) has been granted a cultivation license under the Access to Cannabis for Medical Purposes Regulations (the "ACMPR"). Beleave becomes CW's fifth licensed producer partner.

Beleave Obtains ACMPR Licence to Cultivate Medical Cannabis

2017-05-19 marketwired
TORONTO, ONTARIO--(Marketwired - May 19, 2017) - Beleave Inc. ("Beleave" or the "Company") (CSE:BE)(CSE:BE.CN)(CNSX:BE) is pleased to announce that its wholly-owned subsidiary, First Access Medical Inc. ("FAM"), has been granted a licence to cultivate medical cannabis pursuant to the Access to Cannabis for Medical Purposes Regulations (the "ACMPR").

Beleave Announces Non-Dilutive Interim Streaming Agreement with PanCann to Finance Construction of a Proposed Second Production Facility

2017-05-05 marketwired
TORONTO, ON--(Marketwired - May 05, 2017) - Beleave Inc. (CSE: BE) (CSE: BE.CN) (CNSX: BE) ("Beleave" or the "Company") is pleased to announce that it has entered into an interim streaming agreement with PanCann Streaming Corp. ("PanCann") to finance the purchase and construction of a proposed second production facility to be identified, in exchange for equity participation in, and a production yield allocation from the proposed facility.